Contouring With Neuromodulators

Dermatol Surg. 2024 Sep 1;50(9S):S97-S102. doi: 10.1097/DSS.0000000000004345. Epub 2024 Jul 31.

Abstract

Background and objective: Botulinum toxins, originally used for facial rejuvenation, have emerged as a promising tool for sculpting and refining contours for both the face and body.

Methods: The peer-reviewed literature on neuromodulator contouring treatments was analyzed, with a particular emphasis on studies and case reports involving the use of botulinum toxin type A.

Results: Modification of face, neck, shoulder, arm, and calf contour has been reported. Treatment and dosing protocols vary with the strength and depth of the target muscle. Regional effects of neuromodulator treatment begin to appear approximately 2 weeks after injection and are often most prominent at the 70- to 90-day time point. Although treatments are generally well tolerated, short-term muscle weakness and other side effects may occur.

Conclusion: The use of neuromodulators to enhance facial and body contours has demonstrated efficacy, but further research is needed to validate their use and explore the full potential of this intervention through larger randomized controlled trials. The application of neuromodulators as a minimally invasive tool to address the rising demand for nonsurgical body sculpting represents a promising frontier in aesthetics.

Publication types

  • Review

MeSH terms

  • Body Contouring / adverse effects
  • Body Contouring / methods
  • Botulinum Toxins, Type A* / administration & dosage
  • Botulinum Toxins, Type A* / adverse effects
  • Cosmetic Techniques
  • Face
  • Humans
  • Neuromuscular Agents / administration & dosage
  • Neuromuscular Agents / adverse effects
  • Neurotransmitter Agents* / administration & dosage
  • Neurotransmitter Agents* / therapeutic use
  • Rejuvenation
  • Skin Aging / drug effects

Substances

  • Botulinum Toxins, Type A
  • Neurotransmitter Agents
  • Neuromuscular Agents